- Letter to the Editor
- Open Access
Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
JA Clinical Reportsvolume 5, Article number: 33 (2019)
To the Editor,
We read with great interest the case report by Moriwaki and Kayashima  in the journal. The authors described the patient demonstrating prolonged neuromuscular blockade even after administration of sugammadex considered as appropriate for reversal of rocuronium. After the surgery, the long-lasting residual blockade was antagonized by supplemental administration of neostigmine and atropine, and the patient’s trachea was extubated without any complications. Although the course and the explanation were acceptable, we have several concerns for the case.
First, the authors administered neostigmine and atropine. The reversal temporally increased the train of four ratio; however, no one can predict the duration of prolonging blockade and the half time of neostigmine is approximately 1 h. The patient showed the apparent residual blockade even after 163 min from the induction of anesthesia. More length of time might be required for the complete recovery . Intensive care and careful observation would be appreciated.
Second, the authors emphasized the effect of magnesium and calcium-antagonists on acetylcholine release. The combination is well known for the treatment of cholinergic crisis in the area of toxicology . The non-depolarizing neuromuscular blocking agents have presynaptic inhibitory effect on neuronal acetylcholine receptors . The residual blockade might be so complicated and there was a room for discussion.
We previously reported the case of a patient developing recurarization after administration of sugammadex following a prolonged rocuronium infusion . In the case, unexpected decrease of elimination of rocuronium by hypothermia might be a factor of the recurarization. The cause of unexpected prolongation and residual of neuromuscular blockade varies [6, 7]. Residual neuromuscular blockade absolutely could not be overlooked after anesthesia . Anesthesiologists should pay more attention to prolonged neuromuscular blockade.
Moriwaki K, Kayashima K. Prolonged neuromuscular blockade and insufficient reversal after sugammadex administration in cesarean section under general anesthesia: a case report. JA Clin Rep. 2019;5:28.
Ezri T, Evron S, Petrov I, Schachter P, Berlovitz Y, Shimonov M. Residual Curarization and postoperative respiratory complications following laparoscopic sleeve gastrectomy. The effect of reversal agents: sugammadex vs. neostigmine. J Crit Care Med. 2015;1:61–7.
Brvar M, Chan MY, Dawson AH, Ribchester RR, Eddleston M. Magnesium sulfate and calcium channel blocking drugs as antidotes for acute organophosphorus insecticide poisoning - a systematic review and meta-analysis. Clin Toxicol. 2018;56:725–36.
Takagi S, Adachi YU, Saubermann AJ, Vizi ES. Presynaptic inhibitory effects of rocuronium and SZ1677 on [3H]acetylcholine release from the mouse hemidiaphragm preparation. Neurochem Int. 2002;40:655–9.
Murata T, Kubodera T, Ohbayashi M, Murase K, Adachi YU, Matsuda N. Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia. Can J Anesth. 2013;60:508–9.
Sung TY, You HJ, Cho CK, Choi HR, Kim YB, Shin YS, Yang HS. Effects of magnesium chloride on rocuronium-induced neuromuscular blockade and sugammadex reversal in an isolated rat phrenic nerve-hemidiaphragm preparation: an in-vitro study. Eur J Anaesthesiol. 2018;35:193–9.
Thevathasan T, Shih SL, Safavi KC, Berger DL, Burns SM, Grabitz SD, Glidden RS, Zafonte RD, Eikermann M, Schneider JC. Association between intraoperative non-depolarising neuromuscular blocking agent dose and 30-day readmission after abdominal surgery. Br J Anaesth. 2017;119:595–605.
Esteves S. Can residual paralysis be avoided?: a critical appraisal of the use of sugammadex. Eur J Anaesthesiol. 2015;32:663–5.
No funding declared.
Availability of data and materials
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.